Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)

Revenue by Segment

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Services Toll Manufacturing	284.79M	181.87M	134.01M	132.44M	77.49M
Services Toll Manufacturing Growth	56.59%	35.71%	1.18%	70.91%	52.42%
Production and Selling of Pharmaceutical Products	3.81B	2.59B	1.79B	1.35B	1.17B
Production and Selling of Pharmaceutical Products Growth	47.33%	44.65%	32.32%	15.62%	28.55%
Total	4.10B	2.77B	1.92B	1.48B	1.25B
Total Growth	47.94%	44.03%	29.54%	19.06%	29.81%

Revenue by Geography

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Egypt	3.85B	2.63B	1.74B	1.38B	1.16B
Egypt Growth	46.68%	50.76%	26.47%	18.89%	27.28%
Export	243.55M	142.20M	180.24M	106.51M	87.87M
Export Growth	71.27%	-21.11%	69.23%	21.21%	75.96%
Total	4.10B	2.77B	1.92B	1.48B	1.25B
Total Growth	47.94%	44.03%	29.54%	19.06%	29.81%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 25, 2026

Data Sources Report a data error